However, unlike BRAF-mutant cells, small interfering RNA (siRNA)–mediated KSR1/2 depletion in tumor cells harboring oncogenic RAS induced a potent apoptotic response (Fig. 8A), indicating that APS-2-79 was not efficiently inhibiting KSR activity. This evidence concerns the gene KSR1 and neoplasm.